News
Post-COVID boardroom shifts and policy tailwinds are catalysing a once-in-a-generation opportunity, Khemani says ...
While Donald Trump spared pharma companies from his tariff announcement last week, he revealed yesterday plans to announce ...
The last time the inauguration was held inside was in 1985 when Ronald Reagan started his second term when temperatures in ...
With a lack of real breakthroughs since the 1960s, older methods such as electrical-based therapies are experiencing a revival in psychiatry.
Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...
Millennium Pharma, and GSK. Narasimhan said Marshall is "an esteemed biomedical scientist and an accomplished biopharmaceuticals research leader" with "three decades of experience leading drug ...
Veranova appoints Dr Scott Zugel as global VP of analytical research development operations: Devens, Massachusetts Tuesday, ...
Takeda had high hopes for alisertib – one of the top assets in its $8.8 billion buyout of Millennium Pharma way back in 2008 – but those were dashed in 2015 when the drug failed to move the ...
StockNews.com assumed coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a research report report published on Sunday morning. The brokerage issued a sell rating on the specialty ...
NHS Hospital IT Leaders Cite Delayed Procurement, Interoperability Concerns, and Vendor Reevaluation as System Restructuring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results